WO2020259367A1 - 一种药线引流治疗装置 - Google Patents

一种药线引流治疗装置 Download PDF

Info

Publication number
WO2020259367A1
WO2020259367A1 PCT/CN2020/096588 CN2020096588W WO2020259367A1 WO 2020259367 A1 WO2020259367 A1 WO 2020259367A1 CN 2020096588 W CN2020096588 W CN 2020096588W WO 2020259367 A1 WO2020259367 A1 WO 2020259367A1
Authority
WO
WIPO (PCT)
Prior art keywords
absorbent cotton
medical thread
woven fabric
wound
tube
Prior art date
Application number
PCT/CN2020/096588
Other languages
English (en)
French (fr)
Inventor
龙丹
Original Assignee
龙丹
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 龙丹 filed Critical 龙丹
Priority to US17/595,506 priority Critical patent/US20220265476A1/en
Publication of WO2020259367A1 publication Critical patent/WO2020259367A1/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/05—Bandages or dressings; Absorbent pads specially adapted for use with sub-pressure or over-pressure therapy, wound drainage or wound irrigation, e.g. for use with negative-pressure wound therapy [NPWT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H9/00—Pneumatic or hydraulic massage
    • A61H9/005—Pneumatic massage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H9/00—Pneumatic or hydraulic massage
    • A61H9/005—Pneumatic massage
    • A61H9/0078—Pneumatic massage with intermittent or alternately inflated bladders or cuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
    • A61M1/91—Suction aspects of the dressing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
    • A61M1/91—Suction aspects of the dressing
    • A61M1/915—Constructional details of the pressure distribution manifold
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
    • A61M1/92—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing with liquid supply means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
    • A61M1/94—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing with gas supply means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M19/00—Local anaesthesia; Hypothermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0468—Specially adapted for promoting wound healing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0472—Structure-related aspects
    • A61N1/0492—Patch electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/326—Applying electric currents by contact electrodes alternating or intermittent currents for promoting growth of cells, e.g. bone cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36003—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of motor muscles, e.g. for walking assistance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00365—Plasters use
    • A61F2013/00536—Plasters use for draining or irrigating wounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00902—Plasters containing means
    • A61F2013/00936—Plasters containing means metal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/10—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2205/00—Devices for specific parts of the body
    • A61H2205/10—Leg
    • A61H2205/106—Leg for the lower legs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2209/00—Devices for avoiding blood stagnation, e.g. Deep Vein Thrombosis [DVT] devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/054—General characteristics of the apparatus combined with other kinds of therapy with electrotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/36021—External stimulators, e.g. with patch electrodes for treatment of pain

Definitions

  • the invention belongs to the field of therapeutic devices, and specifically relates to a medical thread drainage therapy device.
  • post-surgical analgesia are medication analgesia.
  • Postoperative medication analgesia causes a series of side effects such as lethargy and muscle relaxation of both lower limbs, which may cause deep vein thrombosis.
  • Subcutaneous fluid and excess coagulation factors cannot be extracted. These are very disadvantageous to rapid surgical recovery.
  • Continuous negative pressure drainage is affected by tissue coagulation and leads to wound pain.
  • the incidence of systemic complications (such as heart-pulmonary dysfunction, venous thrombosis, etc.) after surgery such as abdominal surgery is still as high as 20%-60 %.
  • the present invention proposes a medical thread drainage treatment device, which is a new multi-mode treatment technology with convenient use and accurate curative effect.
  • the core of the technical treatment is: 1. Provide postoperative multi-mode machine electrical anesthesia for pain relief , Drug thread infiltration anesthesia, application of penetrating pain relief, "Electric energy promotes the relief of interneuronal edema" and the elicitation of subcutaneous fluid, which are five major pain relief modes, reducing the side effects of morphine use. 2. Provide multi-therapies to promote rapid wound healing, electrical stimulation of wound healing, promote blood circulation, further oxygen supply to the wound and positive charge potassium, calcium and magnesium ions to cover the wound and the subcutaneous fluid of the wound surface through the negative pressure of the drug thread.
  • Negative pressure drainage of electric medicine thread makes the wound subcutaneous fluid and coagulation factors leak out without entering the blood.
  • Electrical interference with coagulation factors promotes their rapid decomposition.
  • Electricity speeds up healing and reduces the number of coagulation factors.
  • Electrical pain relief and barrier-free movement (6) Electrical pressure on the calf to increase blood return.
  • a medical thread drainage treatment device comprising:
  • the first treatment unit is used for postoperative analgesia; preferably multi-modal analgesia.
  • the multi-modal analgesia of the first treatment unit means that a suitable analgesic mode can be selected from a variety of analgesic modes clinically, and the multi-modal analgesia Including: electrical anesthesia, infiltration anesthesia, medical thread drainage analgesia and patch penetration analgesia;
  • the second treatment unit is used to promote rapid wound healing; preferably, multi-therapies are used to promote rapid wound healing.
  • the multi-therapy of the second treatment unit promotes rapid wound healing refers to the clinically possible ways to promote rapid wound healing Choose suitable therapies from among the multiple therapies, including: promotion of blood circulation, electrical stimulation, oxygen supply and positive charge coverage, and subcutaneous fluid on the wound surface through the negative pressure of the drug thread.
  • the third treatment unit is used to prevent deep venous thrombosis; preferably, multiple methods are used to prevent deep venous thrombosis, and the multiple methods include two or more of the following methods: (1) Electricity medicine line negative pressure comprehensive drainage wound to cause subcutaneous fluid accumulation And coagulation factor exudation; (2) electrical interference with coagulation factors to promote their rapid decomposition; (3) electrical stimulation of the calf muscles to promote muscle contraction to accelerate venous blood flow; (4) electricity to accelerate healing and reduce the number of coagulation factors; (5) Electrical pain relief, barrier-free movement; (6) Electrical pressure on the calf increases the return blood volume;
  • the electric pressure negative piezoelectric energy stimulation comprehensive treatment machine is respectively connected with the first treatment unit, the second treatment unit and the third treatment unit and provides electric pressure negative piezoelectric energy.
  • the first treatment unit includes: a first medical thread, a first non-woven fabric, a first absorbent cotton, two first suction tube discs, and a first suction device for sucking out liquid on the wound after being connected to a negative pressure suction device.
  • the first absorbent cotton is arranged in the middle position on the first non-woven fabric; the first medical thread is arranged on the first absorbent cotton; the discs of the two first suction tube discs are respectively arranged on the On both ends of the first absorbent cotton, one of the tube portions of the first suction tube coil is connected to the first negative pressure tube, and the other first suction tube coil portion is connected to the first pressure reducing tube;
  • the first metal wire sockets (through the hydrogel) are respectively arranged at two corners of the first non-woven fabric and are respectively connected to the electric pressure negative piezoelectric energy stimulation comprehensive treatment machine.
  • a first gel is used to evenly coat the first non-woven fabric on the side where the first absorbent cotton is located to fix the first medical thread and the first absorbent cotton covering the wound.
  • first absorbent cotton is fixed on the first non-woven fabric by the first colloid; the first medical thread is fixed on the first absorbent cotton by the first colloid.
  • the first medicine thread is used for non-surgical wounds without infiltrating drugs, for wound infiltration anesthesia, for infiltration of lidocaine cream, and for wound pain relief, to infiltrate the first mixed drug.
  • the first compounding medicine includes: Yuanhu, mountain eggplant, Chuandongzi, Shanxi, Ligusticum chuanxiong, Angelica, Rhubarb, Asarum, Asafoetida, Frankincense, Turmeric, Diclofenac, Maqianzi, Borneol, Zhizhi Seed, Angelica dahurica and Scutellaria baicalensis Georgi each 10 grams, cumin, myrrh, male clove, red peony root, woody, cork, peppermint oil and winter clear oil each 5 grams, musk and chili oil each 3 grams, and diphenhydramine 1g.
  • the first mixed compound is mixed with the first colloid.
  • the second treatment unit includes: a second medicinal thread, a second non-woven fabric, a second absorbent cotton, two second suction tube discs, and a second suction device for sucking out liquid on the wound after being connected to a negative pressure suction device.
  • the second absorbent cotton is arranged in the middle of the second non-woven fabric; the second medical thread is arranged on the second absorbent cotton; the discs of the two second suction tube discs are respectively arranged on At the two ends of the second absorbent cotton on the same side of the edge, one of the second suction tube coil part is connected to the second negative pressure tube, and the other second suction tube coil part is connected to the oxygen supply tube and the flushing tube Respectively connected; the two second metal wire sockets (through hydrogel) are respectively arranged on the second non-woven fabric and arranged on both sides of the second absorbent cotton and are respectively integrated with the electrical pressure negative piezoelectric energy stimulation The treatment machine is connected.
  • a second compound drug or metal ion is adhered to the second drug thread.
  • the second absorbent cotton is fixed on the second non-woven fabric by the second colloid; the second medical thread is fixed on the second absorbent cotton by the second colloid.
  • a second glue is used to evenly coat the second non-woven fabric on the side where the second absorbent cotton is located to fix the second medical thread and the second absorbent cotton to cover the wound.
  • a second compounding agent or the metal ion is mixed in the second colloid.
  • the second compounding medicine includes: 8g each of natural bezoar, camphor, pearl, red stone fat, amber, yellow almond, frankincense, and myrrh, 15g each of calamine, calcined gypsum, keel, light powder, and 1.5 borneol. g.
  • the third treatment unit includes: a wound treatment module for wounds and two auxiliary treatment modules for attaching to the lower leg muscles;
  • the wound treatment module and the auxiliary treatment module are respectively connected with the electric pressure negative piezoelectric energy stimulation comprehensive treatment machine.
  • the wound treatment module and the auxiliary treatment module are respectively connected to the electric pressure and negative piezoelectric energy stimulation comprehensive treatment machine, which can achieve the effect of non-coagulation and smooth flow of wound exudate through electric stimulation and medical thread, and induce excess coagulation factors from the wound And subcutaneous fluid to prevent it from entering the blood and causing deep vein thrombosis.
  • the method for the third treatment unit to prevent deep venous thrombosis is: (1) the negative pressure of the electric energy medicine thread comprehensively drains the wound to make the subcutaneous fluid and coagulation factor exudate; (2) the electrical interference with the coagulation factor promotes its rapid decomposition (3) Electrically stimulate the calf muscles to promote muscle contraction and speed up the venous blood flow; (4) Electricity speeds up healing, reducing the number of coagulation factors; (5) Electrical pain relief, barrier-free movement; (6) Electrical pressure on the calf to restore blood volume increase.
  • the wound treatment module includes: a third medical thread, a third non-woven fabric, a third absorbent cotton, a third suction tube disk, and a third negative pressure tube for sucking out liquid on the wound after being connected to a negative pressure suction device And two third metal wire sockets;
  • the third absorbent cotton is arranged at the middle position on the third non-woven fabric; the third medical thread is arranged on the third absorbent cotton; the third suction tube disc is arranged on the third absorbent cotton
  • the middle part of the upper part is connected with the third negative pressure tube; the two third metal wire sockets (through hydrogel) are respectively arranged on the third non-woven fabric and arranged on both sides of the third absorbent cotton and are respectively connected with The electrical pressure negative piezoelectric energy can stimulate the connection of the comprehensive treatment machine.
  • the auxiliary treatment module includes: a fourth medical thread, a fourth non-woven fabric, a fourth absorbent cotton, an airbag bag, and two fourth metal wire sockets;
  • the fourth absorbent cotton is arranged in the middle position of the fourth non-woven fabric; the fourth medical thread is arranged on the fourth absorbent cotton; the two fourth metal wire sockets (through the hydrogel ) Are respectively arranged on the fourth non-woven fabric and arranged on both sides of the fourth absorbent cotton, and are respectively connected to the electric pressure-negative piezoelectric energy stimulation comprehensive treatment machine; the airbag bag is arranged opposite to the fourth The other side of the fourth non-woven fabric of absorbent cotton.
  • the third drug line is mixed and compounded for the treatment of patients with high coagulation and high risk, and has a third mixed and compounded medicine with the function of promoting blood circulation and removing stasis;
  • the third compounding medicine includes: Panax notoginseng, safflower, citron, astragalus, Codonopsis, Ligusticum chuanxiong, green peel, peach kernel, red peony root, Citrus aurantium, Cyperus rotundus 10g each, Salvia miltiorrhiza, Typhae, Atractylodes, Yam, Frankincense, Chai Hu, Chuanmeizi, Taizishen, Roasted Licorice each 8g and aspirin 1g.
  • the third drug line is not mixed with the third mixed drug, it is used for the treatment of non-hypercoagulable high-risk patients.
  • the metal ions are mixed in the hydrogel, and when the hydrogel mixed with the metal ions covers the wound, it absorbs and activates the negatively charged growth factors and proteases to accumulate to the wound, and accelerate the wound healing.
  • the metal ion is potassium ion or a mixed ion of potassium ion, sodium ion, calcium ion and magnesium ion.
  • the main physiological function of the potassium ion is to maintain cell metabolism and activate the activity of protease
  • the sodium ions help the normal operation of nerves and muscles in the body
  • the calcium ion is a coagulation factor, and activates the coagulation factor to participate in the coagulation process;
  • the magnesium ions are used to activate the activities of various enzymes in the human body.
  • the fourth drug line is mixed with the third mixed drug or no drug is mixed.
  • first non-woven fabric, the second non-woven fabric, the third non-woven fabric and the fourth non-woven fabric can all be replaced by a PU film.
  • the first glue is hot melt glue.
  • the second glue is hot melt glue.
  • the medical thread drainage treatment device of the present invention includes a first treatment unit, a second treatment unit, and a third treatment unit.
  • the clinician can select the corresponding treatment unit according to clinical needs: the first treatment unit in the first treatment unit Most of the drugs in the second treatment unit are analgesic and local anesthetic drug formulations for infiltration and pain relief; the drugs in the second drug line in the second treatment unit are mostly wound healing formulas for rapid wound healing; the third treatment unit Most of the drugs are activating blood and removing blood stasis drug formulas.
  • the drug thread is inserted into the wound for anticoagulation and drainage; it is used to achieve rapid multi-mode pain relief of chronic complex wounds and post-operative wounds and rapid wound healing with multiple treatments, and multiple methods to prevent postoperative deep Venous thrombosis greatly reduces postoperative complications, especially pulmonary embolism caused by deep vein thrombosis, and saves patients' lives.
  • Fig. 1 is a schematic structural diagram of a first treatment unit in an embodiment of the present invention.
  • Fig. 2 is a schematic structural diagram of a second treatment unit in an embodiment of the present invention.
  • Fig. 3 is a schematic structural diagram of a treatment module of a third treatment unit in an embodiment of the present invention.
  • FIG. 4 is a schematic structural diagram of an auxiliary treatment module of a third treatment unit in an embodiment of the present invention.
  • 21-Second drug thread 22-Second non-woven fabric, 23-Second absorbent cotton, 24-,Second straw tray, 25-Second negative pressure tube, 26-Oxygen supply tube, 27-Flush tube, 28 -The second metal wire socket;
  • 321-fourth medical thread 322-fourth non-woven fabric, 323-fourth absorbent cotton, 324-air bag bag, 325-fourth metal wire socket.
  • this embodiment provides a medical thread drainage treatment device, the treatment device includes:
  • the first treatment unit is used for postoperative analgesia; preferably multi-modal analgesia.
  • the multi-modal analgesia of the first treatment unit means that a suitable analgesic mode can be selected from a variety of analgesic modes clinically, and the multi-modal analgesia Including: electrical anesthesia, infiltration anesthesia, medical thread drainage analgesia and patch penetration analgesia;
  • the second treatment unit is used to promote rapid wound healing; preferably, multi-therapies are used to promote rapid wound healing.
  • the multi-therapy of the second treatment unit promotes rapid wound healing refers to the clinically possible ways to promote rapid wound healing Choose suitable therapies from among the multiple therapies, including: promotion of blood circulation, electrical stimulation, oxygen supply and positive charge coverage, and subcutaneous fluid on the wound surface through the negative pressure of the drug thread.
  • the third treatment unit is used to prevent deep venous thrombosis; preferably, multiple methods are used to prevent deep venous thrombosis, and the multiple methods include two or more of the following methods: (1) Electricity medicine line negative pressure comprehensive drainage wound to cause subcutaneous fluid accumulation And coagulation factor exudation; (2) electrical interference with coagulation factors to promote their rapid decomposition; (3) electrical stimulation of the calf muscles to promote muscle contraction to accelerate venous blood flow; (4) electricity to accelerate healing and reduce the number of coagulation factors; (5) Electrical pain relief, barrier-free movement; (6) Electrical pressure on the calf increases the return blood volume;
  • the electric pressure negative piezoelectric energy stimulation comprehensive treatment machine is respectively connected with the first treatment unit, the second treatment unit and the third treatment unit and provides electric pressure negative piezoelectric energy.
  • the drugs in the first drug line in the first treatment unit are mostly analgesic and local anesthetic drug formulations for infiltration and pain relief;
  • the second drug in the second treatment unit The drugs in the thread are mostly wound healing formulas, which are used for rapid wound healing;
  • the drugs in the third treatment unit are mostly blood-activating and stasis-removing drug formulas, and the drug thread is inserted into the wound for anticoagulation and drainage; used to achieve chronic complex wounds
  • multiple methods to prevent postoperative deep vein thrombosis greatly reduce postoperative complications, especially reduce pulmonary embolism caused by deep vein thrombosis, and save patients' lives.
  • the first treatment unit includes: a first medical thread, a first non-woven fabric, a first absorbent cotton, two first suction tube discs, used for connecting with a negative pressure suction device The first negative pressure tube, the first pressure reducing tube and the two first metal wire sockets for sucking out the liquid on the wound;
  • the first absorbent cotton is arranged in the middle position on the first non-woven fabric; the first medical thread is arranged on the first absorbent cotton; the discs of the two first suction tube discs are respectively arranged on the On both ends of the first absorbent cotton, one of the tube portions of the first suction tube coil is connected to the first negative pressure tube, and the other first suction tube coil portion is connected to the first pressure reducing tube;
  • the first metal wire sockets (through the hydrogel) are respectively arranged at two corners of the first non-woven fabric and are respectively connected to the electric pressure negative piezoelectric energy stimulation comprehensive treatment machine.
  • a first gel is used to evenly coat the first non-woven fabric on the surface where the first absorbent cotton is located to fix the first medical thread and the first absorbent cotton covering the wound.
  • the first absorbent cotton is fixed on the first non-woven fabric by the first colloid; the first medical thread is fixed on the first absorbent cotton by the first colloid .
  • the first drug thread is used for non-surgical wounds without infiltrating drugs, for wound infiltration anesthesia, for infiltration of lidocaine cream, and for wound pain relief, to infiltrate the first mixed drug.
  • the first compounding medicine includes: Yuanhu, mountain eggplant, Chuandongzi, Shanxi, Chuanxiong, Angelica, Rhubarb, Asarum, Asafoetida, Frankincense, Turmeric, Diclofenac, Strychnoma, Borneol, 10g each of Gardenia, Angelica dahurica and Scutellaria baicalensis, cumin, myrrh, male clove, red peony, woody, cork, 5g each of peppermint oil and winter oil, 3g each of musk and chili oil, diphenhydramine 1g.
  • the first compound is mixed with the first colloid.
  • the second treatment unit includes: a second medical thread, a second non-woven fabric, a second absorbent cotton, two second suction tube discs, for connecting with a negative pressure suction device A second negative pressure tube for sucking out liquid on the wound, an oxygen supply tube for supplying oxygen to the wound, an irrigation tube for cleaning the wound, and two second metal wire sockets;
  • the second absorbent cotton is arranged in the middle of the second non-woven fabric; the second medical thread is arranged on the second absorbent cotton; the discs of the two second suction tube discs are respectively arranged on At the two ends of the second absorbent cotton on the same side of the edge, one of the second suction tube coil part is connected to the second negative pressure tube, and the other second suction tube coil part is connected to the oxygen supply tube and the flushing tube Respectively connected; the two second metal wire sockets (through hydrogel) are respectively arranged on the second non-woven fabric and arranged on both sides of the second absorbent cotton and are respectively integrated with the electrical pressure negative piezoelectric energy stimulation The treatment machine is connected.
  • the second compound or metal ion adheres to the second drug thread.
  • the second absorbent cotton is fixed on the second non-woven fabric by the second glue; the second medical thread is fixed on the second absorbent cotton by the second glue .
  • a second gel is used to evenly coat the second non-woven fabric on the surface where the second absorbent cotton is located to fix the second medical thread and the second absorbent cotton to cover the wound.
  • the second compound is mixed with the second colloid or the metal ion is mixed.
  • the second compounding medicine includes: natural bezoar, camphor, pearl, red stone fat, amber, yellow almond, frankincense, myrrh each 8g, calamine, calcined gypsum, keel, light powder each 15g , Borneol 1.5g.
  • the third treatment unit includes: a wound treatment module for wounds and two auxiliary treatment modules for attaching to the calf muscles of both lower limbs;
  • the wound treatment module and the auxiliary treatment module are respectively connected with the electric pressure negative piezoelectric energy stimulation comprehensive treatment machine.
  • the wound treatment module and the auxiliary treatment module are respectively connected to the electrical pressure-negative piezoelectric energy stimulation comprehensive treatment machine, which can achieve the effect of non-coagulation and smooth flow of wound exudate through electrical stimulation and medical thread, and lead out from the wound Excess coagulation factors and subcutaneous fluid avoid entering the blood and causing deep vein thrombosis.
  • the method for the third treatment unit to prevent deep venous thrombosis is: (1) the negative pressure of the electric energy medicine line comprehensively drains the wound to make the subcutaneous fluid and coagulation factor exudate, (2) the electrical interference with the coagulation factor promotes It breaks down quickly. (3) Electrically stimulate the calf muscles to promote muscle contraction and speed up venous blood flow. (4) Electricity speeds up healing, reducing the number of coagulation factors. (5) Electrical pain relief and barrier-free movement. (6) Electrical pressure on the calf to increase blood return.
  • the wound treatment module includes: a third medical thread, a third non-woven fabric, a third absorbent cotton, a third suction tube disk, which is used to suck out the wound after being connected with a negative pressure suction device
  • the third negative pressure tube for liquid and two third metal wire sockets;
  • the third absorbent cotton is arranged at the middle position on the third non-woven fabric; the third medical thread is arranged on the third absorbent cotton; the third suction tube disc is arranged on the third absorbent cotton
  • the middle part of the upper part is connected with the third negative pressure tube; the two third metal wire sockets (through hydrogel) are respectively arranged on the third non-woven fabric and arranged on both sides of the third absorbent cotton and are respectively connected with The electrical pressure negative piezoelectric energy can stimulate the connection of the comprehensive treatment machine.
  • the auxiliary treatment module includes: a fourth medical thread, a fourth non-woven fabric, a fourth absorbent cotton, an airbag bag, and two fourth metal wire sockets;
  • the fourth absorbent cotton is arranged in the middle position of the fourth non-woven fabric; the fourth medical thread is arranged on the fourth absorbent cotton; the two fourth metal wire sockets (through the hydrogel ) Are respectively arranged on the fourth non-woven fabric and arranged on both sides of the fourth absorbent cotton, and are respectively connected to the electric pressure-negative piezoelectric energy stimulation comprehensive treatment machine; the airbag bag is arranged opposite to the fourth The other side of the fourth non-woven fabric of absorbent cotton.
  • the third drug line compounding is used for the treatment of patients with high coagulation and high risk, which has the effect of promoting blood circulation and removing blood stasis;
  • the third compounding medicine includes: Panax notoginseng, safflower, citron, astragalus, Codonopsis, Ligusticum chuanxiong, green peel, peach kernel, red peony root, Citrus aurantium, Cyperus rotundus 10g each, Salvia miltiorrhiza, Typhae, Atractylodes, Yam, Frankincense, Chai Hu, Chuanmeizi, Taizishen, Roasted Licorice each 8g and aspirin 1g.
  • the third drug line when the third drug line is not mixed with the third compound, it is used for the treatment of non-hypercoagulable and high-risk patients.
  • the metal ions are mixed in the hydrogel, and when the hydrogel mixed with the metal ions covers the wound, it absorbs and activates the negatively charged growth factors and proteases to accumulate to the wound and accelerate the wound healing .
  • the metal ion is potassium ion or a mixed ion of potassium ion, sodium ion, calcium ion and magnesium ion.
  • the main physiological function of potassium ions is to maintain cell metabolism and activate protease activity
  • the sodium ions help the normal operation of nerves and muscles in the body
  • the calcium ion is a coagulation factor, and activates the coagulation factor to participate in the coagulation process;
  • the magnesium ions are used to activate the activities of various enzymes in the human body.
  • the fourth drug line is compounded with the third compound or no drugs are compounded.
  • the first non-woven fabric, the second non-woven fabric, the third non-woven fabric and the fourth non-woven fabric can all be replaced by a PU film.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Rehabilitation Therapy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

一种药线引流治疗装置。所述治疗装置包括：第一治疗单元，用于术后止痛；第二治疗单元，用于促进伤口快速愈合；第三治疗单元，用于预防深静脉血栓；电气压负压电能刺激综合治疗机，分别与所述第一治疗单元、第二治疗单元和第三治疗单元连接并提供电气压负压电能。

Description

一种药线引流治疗装置 技术领域
本发明属于治疗装置领域，具体涉及一种药线引流治疗装置。
背景技术
目前，外科手术后的止痛均为药物止痛治疗，术后药物止痛引起病人嗜睡、双下肢肌肉松弛等一系列副作用，可能引起深静脉血栓发生。再加上对手术伤口的处理除了消毒换纱布和敷料，没有实质性的治疗方法，创面皮下积液及多余的凝血因子不能引出，这些对外科快速康复是很不利的。持续性负压引流因受组织凝固影响而引出不畅导致伤口疼痛，外科手术如腹部手术后患者全身并发症(如心－肺功能障碍、静脉血栓形成等)的发生率仍高达20％-60％。有的情况下，手术虽然安全实施，但治疗结果不甚理想，患者术后出现并发症甚至致命，因此，外科医生时曾面临“手术成功、治疗失败甚至患者致命的“尴尬”局面。在任何一家医院，此类情况绝非罕见，而对手术导致的创伤并发症如深静脉血栓，缺乏行之有效的预防治疗方法，创伤快速愈合康复就无法很好进行。
综上，针对以上缺点，需要提供一种技术方案来克服或至少减轻现有技术上的缺陷。
发明内容
为解决上述问题，本发明提出一种药线引流治疗装置，所述治疗装置为使用方便、疗效确切的多模式治疗新技术，其技术治疗核心是，一、提供术后多模式机器电麻止痛、药线浸润麻醉、敷贴渗透止痛，“电能促进神经间水肿缓解”以及皮下积液的引出等五大缓解疼痛模式，减少吗啡使用带来副作用。二、提供多疗法促进伤口快速愈合，电刺激伤口愈合，促进血液循环，进一步伤口供氧及正电荷钾钙镁离子覆盖伤口及创面皮下积液通过药线负压引出等五大多疗法促进伤口快速愈合。三、提供术后多方法解除深静脉血栓形成病因，所述多方法包括：(1)电能药线负压引流使伤口皮下积液和凝血因子畅通渗出而不进入血液。(2)电干扰凝血因子，促其快速分解。(3)电刺激小腿肌肉，促进肌肉收缩静脉血流加快(4)电加快愈合，凝血因子数量减少(5)电止痛，活动无障碍(6)电气压小腿，使回心血量增加等术后六大方法解除病因预防深静脉血栓。本发明在外科术后快速愈合康复上使用，临床使用指南推广，将大幅度降低乃至消灭术后并发 症特别是肺栓塞的术后并发症这一世界难题的发生，挽救患者生命。
本发明是通过以下技术方案实现的：
一种药线引流治疗装置，所述治疗装置包括：
第一治疗单元，用于术后止痛；优选为多模式止痛，所述第一治疗单元的多模式止痛指的是临床上可以在多种止痛模式中选择适合的止痛模式，所述多模式止痛包括：电麻止痛、浸润麻醉、药线引流止痛和贴片渗透止痛中的两种以上；
第二治疗单元，用于促进伤口快速愈合；优选为采用多疗法来促进伤口快速愈合，所述第二治疗单元的多疗法促进伤口快速愈合指的是临床上可以在多种促进伤口快速愈合方式中选择适合的疗法，所述多疗法包括：促进血液循环、电刺激、供氧及正电荷覆盖和创面皮下积液通过药线负压引出中的两种以上；
第三治疗单元，用于预防深静脉血栓；优选采用多方法来预防深静脉血栓，所述多方法包括以下方法中的两种以上：(1)电能药线负压综合引流伤口使皮下积液和凝血因子渗出；(2)电干扰凝血因子，促其快速分解；(3)电刺激小腿肌肉，促进肌肉收缩静脉血流加快；(4)电加快愈合，凝血因子数量减少；(5)电止痛，活动无障碍；(6)电气压小腿，使回心血量增加；
电气压负压电能刺激综合治疗机，分别与所述第一治疗单元、第二治疗单元和第三治疗单元连接并提供电气压负压电能。
进一步地，所述第一治疗单元包括：第一药线、第一无纺布、第一吸水棉、两个第一吸管盘、用于与负压吸引装置连接后吸出伤口上液体的第一负压管、第一减压管和两个第一金属导线插口；
所述第一吸水棉设置在所述第一无纺布上的中部位置；所述第一药线设置在所述第一吸水棉上；两个所述第一吸管盘的盘部分别设置在所述第一吸水棉的两端上，一个所述第一吸管盘的管部与第一负压管连接，另一个所述第一吸管盘管部与第一减压管连接；两个所述第一金属导线插口(通过水凝胶)分别设置在所述第一无纺布上两角并分别与所述电气压负压电能刺激综合治疗机连接。
进一步地，采用第一胶体均匀涂在所述第一吸水棉所在面的所述第一无纺布上，用以将所述第一药线与第一吸水棉覆盖伤口固定。
进一步地，所述第一吸水棉通过所述第一胶体固定在所述第一无纺布上；所述第一药线通过所述第一胶体固定在所述第一吸水棉上。
进一步地，所述第一药线用于非手术创面时不浸润药物，用于伤口浸润麻醉时浸润利多卡因乳膏，用于伤口止痛时浸润第一混配药。
进一步地，所述第一混配药包括：元胡，山茄子、川棟子，山柰、川芎、当归、大黄、细辛、阿魏、乳香、、姜黄、双氯灭痛，马钱子,冰片，栀子、白芷和黄芩各10克,小茴香、没药、公丁香、赤芍、木香、黄柏，薄荷油和冬清油各5克,麝香和辣椒油各3克,苯海拉明1g。
进一步地，所述第一胶体中混合所述第一混配药。
进一步地，所述第二治疗单元包括：第二药线、第二无纺布、第二吸水棉、两个第二吸管盘、用于与负压吸引装置连接后吸出伤口上液体的第二负压管、用于给伤口提供氧的供氧管、用于清洗伤口的冲洗管和两个第二金属导线插口；
所述第二吸水棉设置在所述第二无纺布上的中部位置；所述第二药线设置在所述第二吸水棉上；两个所述第二吸管盘的盘部分别设置在所述第二吸水棉上同侧的边缘两端，一个所述第二吸管盘管部与第二负压管连接，另一个所述第二吸管盘管部与所述供氧管和冲洗管分别连接；两个所述第二金属导线插口(通过水凝胶)分别设置在第二无纺布上并排列在所述第二吸水棉两侧且分别与所述电气压负压电能刺激综合治疗机连接。
进一步地，所述第二药线上粘附第二混配药或金属离子。
进一步地，所述第二吸水棉通过所述第二胶体固定在所述第二无纺布上；所述第二药线通过所述第二胶体固定在所述第二吸水棉上。
进一步地，采用第二胶体均匀涂在所述第二吸水棉所在面的所述第二无纺布上，将所述第二药线与第二吸水棉覆盖伤口固定。
进一步地，所述第二胶体中混合第二混配药或混合所述金属离子。
进一步地，所述第二混配药包括：天然牛黄、樟脑，珍珠、赤石脂，琥珀、黄丹，乳香、没药各8g，煅炉甘石、煅石膏、龙骨、轻粉各15g，冰片1.5g。
进一步地，所述第三治疗单元包括：用于伤口处的伤口治疗模块和两个用于贴在双下肢小腿肌肉上的辅助治疗模块；
所述伤口治疗模块和辅助治疗模块分别与所述电气压负压电能刺激综合治疗机连接。
进一步地，所述伤口治疗模块和辅助治疗模块分别与所述电气压负压电能刺 激综合治疗机连接，可通过电刺激和药线达到伤口渗液不凝固引流畅通作用，从伤口引出多余凝血因子和皮下积液避免其进入血液引起深静脉血栓。
进一步地，所述第三治疗单元预防深静脉血栓的方法是：(1)电能药线负压综合引流伤口使皮下积液和凝血因子渗出；(2)电干扰凝血因子，促其快速分解；(3)电刺激小腿肌肉，促进肌肉收缩静脉血流加快；(4)电加快愈合，凝血因子数量减少；(5)电止痛，活动无障碍；(6)电气压小腿，使回心血量增加。
进一步地，所述伤口治疗模块包括：第三药线、第三无纺布、第三吸水棉、第三吸管盘、用于与负压吸引装置连接后吸出伤口上液体的第三负压管和两个第三金属导线插口；
所述第三吸水棉设置在所述第三无纺布上的中部位置；所述第三药线设置在所述第三吸水棉上；所述第三吸管盘设置在所述第三吸水棉上的中部并与第三负压管连接；两个所述第三金属导线插口(通过水凝胶)分别设置在第三无纺布上并排列在所述第三吸水棉两侧并分别与所述电气压负压电能刺激综合治疗机连接。
进一步地，所述辅助治疗模块包括：第四药线、第四无纺布、第四吸水棉、气囊袋和两个第四金属导线插口；
所述第四吸水棉设置在所述第四无纺布上的中部位置；所述第四药线设置在所述第四吸水棉上；两个所述第四金属导线插口(通过水凝胶)分别设置在第四无纺布上并排列在所述第四吸水棉两侧，且分别与所述电气压负压电能刺激综合治疗机连接；所述气囊袋设置在相反于所述第四吸水棉的第四无纺布的另一面上。
进一步地，所述第三药线混配用于治疗高凝高危患者的具有活血化淤作用的第三混配药；
所述第三混配药包括：三七、红花、香橼、黄芪、党参、川芎、青皮、桃仁、赤芍、枳壳、香附各10g，丹参、蒲黄、白术、山药、乳香、柴胡、川楝子、太子参、炙甘草各8g和阿斯匹林1g。
进一步地，所述第三药线不混配所述第三混配药时，用于非高凝高危患者的治疗。
进一步地，所述水凝胶中混配所述金属离子，混配金属离子的水凝胶覆盖到 伤口时，吸附并激活带负电荷的生长因子和蛋白酶向伤口聚集，加速伤口愈合。
进一步地，所述金属离子为钾离子或钾离子、钠离子、钙离子和镁离子的混合离子。
进一步地，所述钾离子的主要生理功能是维持细胞的新陈代谢，激活蛋白酶的活性；
所述钠离子在体内有助神经、肌肉的正常运作；
所述钙离子为凝血因子，并激活凝血因子参与凝血过程；
所述镁离子用于激活人体多种酶的活性。
进一步地，所述第四药线混配所述第三混配药或不混配任何药物。
进一步地，所述第一无纺布、第二无纺布、第三无纺布和第四无纺布均可用PU膜代替。
进一步地，所述第一胶体为热熔胶。
进一步地，所述第二胶体为热熔胶。
本发明具有如下有益技术效果：
本发明的一种药线引流治疗装置中包括第一治疗单元、第二治疗单元和第三治疗单元，临床医生可根据临床需要选择相应的治疗单元：第一治疗单元中的第一药线中的药物多为镇痛类和局麻类药物配方，用于浸润止痛；第二治疗单元中第二药线中的药物多为伤口愈合类配方，用于伤口快速愈合；第三治疗单元中的药物多为活血祛瘀类药物配方，药线插入创面内用于抗凝引流；用于实现慢性复杂创面及手术后创面的快速多模式止痛和伤口多疗法快速康复愈合，多方法预防术后深静脉血栓，大幅度减少术后并发症，特别是减少深静脉血栓导致的肺栓塞，挽救患者生命。
附图说明
图1为本发明实施例中第一治疗单元的结构示意图。
图2为本发明实施例中第二治疗单元的结构示意图。
图3为本发明实施例中第三治疗单元的治疗模块的结构示意图。
图4为本发明实施例中第三治疗单元的辅助治疗模块的结构示意图。
附图标记说明：11-第一药线，12-第一无纺布，13-第一吸水棉，14-第一吸管盘，15-第一负压管，16-第一减压管，17-第一金属导线插口；
21-第二药线，22-第二无纺布，23-第二吸水棉，24-,第二吸管盘，25-第二负压管，26-供氧管，27-冲洗管，28-第二金属导线插口；
311-第三药线，312-第三无纺布，313-第三吸水棉，314-第三吸管盘，315-第三负压管，316-第三金属导线插口；
321-第四药线，322-第四无纺布，323-第四吸水棉，324-气囊袋，325-第四金属导线插口。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白，以下结合实施例及说明书附图，对本发明进行进一步详细描述。应当理解，此处所描述的具体实施例仅仅用于解释本发明，并不用于限定本发明。
相反，本发明涵盖任何由权利要求定义的在本发明的精髓和范围上做的替代、修改、等效教学方法以及方案。进一步，为了使公众对本发明有更好的了解，在下文对本发明的细节描述中，详尽描述了一些特定的细节部分。对本领域技术人员来说没有这些细节部分的描述也可以完全理解本发明。
应当明确，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其它实施例，都属于本发明保护的范围。
在本发明实施例中使用的术语是仅仅出于描述特定实施例的目的，而非旨在限制本发明。在本发明实施例和所附权利要求书中所使用的单数形式的“一种”、“所述”和“该”也旨在包括多数形式，除非上下文清楚地表示其他含义。
参考图1～图4，本实施例提出一种药线引流治疗装置，所述治疗装置包括：
第一治疗单元，用于术后止痛；优选为多模式止痛，所述第一治疗单元的多模式止痛指的是临床上可以在多种止痛模式中选择适合的止痛模式，所述多模式止痛包括：电麻止痛、浸润麻醉、药线引流止痛和贴片渗透止痛中的两种以上；
第二治疗单元，用于促进伤口快速愈合；优选为采用多疗法来促进伤口快速愈合，所述第二治疗单元的多疗法促进伤口快速愈合指的是临床上可以在多种促进伤口快速愈合方式中选择适合的疗法，所述多疗法包括：促进血液循环、电刺激、供氧及正电荷覆盖和创面皮下积液通过药线负压引出中的两种以上；
第三治疗单元，用于预防深静脉血栓；优选采用多方法来预防深静脉血栓， 所述多方法包括以下方法中的两种以上：(1)电能药线负压综合引流伤口使皮下积液和凝血因子渗出；(2)电干扰凝血因子，促其快速分解；(3)电刺激小腿肌肉，促进肌肉收缩静脉血流加快；(4)电加快愈合，凝血因子数量减少；(5)电止痛，活动无障碍；(6)电气压小腿，使回心血量增加；
电气压负压电能刺激综合治疗机，分别与所述第一治疗单元、第二治疗单元和第三治疗单元连接并提供电气压负压电能。
临床医生可根据临床需要选择相应的治疗单元：第一治疗单元中的第一药线中的药物多为镇痛类和局麻类药物配方，用于浸润止痛；第二治疗单元中第二药线中的药物多为伤口愈合类配方，用于伤口快速愈合；第三治疗单元中的药物多为活血祛瘀类药物配方，药线插入创面内用于抗凝引流；用于实现慢性复杂创面及手术后创面的快速多模式止痛和伤口多疗法快速康复愈合，多方法预防术后深静脉血栓，大幅度减少术后并发症，特别是减少深静脉血栓导致的肺栓塞，挽救患者生命。
参考图1，在本实施例中，所述第一治疗单元包括：第一药线、第一无纺布、第一吸水棉、两个第一吸管盘、用于与负压吸引装置连接后吸出伤口上液体的第一负压管、第一减压管和两个第一金属导线插口；
所述第一吸水棉设置在所述第一无纺布上的中部位置；所述第一药线设置在所述第一吸水棉上；两个所述第一吸管盘的盘部分别设置在所述第一吸水棉的两端上，一个所述第一吸管盘的管部与第一负压管连接，另一个所述第一吸管盘管部与第一减压管连接；两个所述第一金属导线插口(通过水凝胶)分别设置在所述第一无纺布上两角并分别与所述电气压负压电能刺激综合治疗机连接。
在本实施例中，采用第一胶体均匀涂在所述第一吸水棉所在面的所述第一无纺布上，用以将所述第一药线与第一吸水棉覆盖伤口固定。
在本实施例中，所述第一吸水棉通过所述第一胶体固定在所述第一无纺布上；所述第一药线通过所述第一胶体固定在所述第一吸水棉上。
在本实施例中，所述第一药线用于非手术创面时不浸润药物，用于伤口浸润麻醉时浸润利多卡因乳膏，用于伤口止痛时浸润第一混配药。
在本实施例中，所述第一混配药包括：元胡，山茄子、川棟子，山柰、川芎、当归、大黄、细辛、阿魏、乳香、、姜黄、双氯灭痛，马钱子,冰片，栀子、白芷 和黄芩各10克,小茴香、没药、公丁香、赤芍、木香、黄柏，薄荷油和冬清油各5克,麝香和辣椒油各3克,苯海拉明1g。
在本实施例中，所述第一胶体中混合所述第一混配药。
参考图2，在本实施例中，所述第二治疗单元包括：第二药线、第二无纺布、第二吸水棉、两个第二吸管盘、用于与负压吸引装置连接后吸出伤口上液体的第二负压管、用于给伤口提供氧的供氧管、用于清洗伤口的冲洗管和两个第二金属导线插口；
所述第二吸水棉设置在所述第二无纺布上的中部位置；所述第二药线设置在所述第二吸水棉上；两个所述第二吸管盘的盘部分别设置在所述第二吸水棉上同侧的边缘两端，一个所述第二吸管盘管部与第二负压管连接，另一个所述第二吸管盘管部与所述供氧管和冲洗管分别连接；两个所述第二金属导线插口(通过水凝胶)分别设置在第二无纺布上并排列在所述第二吸水棉两侧且分别与所述电气压负压电能刺激综合治疗机连接。
在本实施例中，所述第二药线上粘附第二混配药或金属离子。
在本实施例中，所述第二吸水棉通过所述第二胶体固定在所述第二无纺布上；所述第二药线通过所述第二胶体固定在所述第二吸水棉上。
在本实施例中，采用第二胶体均匀涂在所述第二吸水棉所在面的所述第二无纺布上，将所述第二药线与第二吸水棉覆盖伤口固定。
在本实施例中，所述第二胶体中混合第二混配药或混合所述金属离子。
在本实施例中，所述第二混配药包括：天然牛黄、樟脑，珍珠、赤石脂，琥珀、黄丹，乳香、没药各8g，煅炉甘石、煅石膏、龙骨、轻粉各15g，冰片1.5g。
在本实施例中，所述第三治疗单元包括：用于伤口处的伤口治疗模块和两个用于贴在双下肢小腿肌肉上的辅助治疗模块；
所述伤口治疗模块和辅助治疗模块分别与所述电气压负压电能刺激综合治疗机连接。
在本实施例中，所述伤口治疗模块和辅助治疗模块分别与所述电气压负压电能刺激综合治疗机连接，可通过电刺激和药线达到伤口渗液不凝固引流畅通作用，从伤口引出多余凝血因子和皮下积液避免其进入血液引起深静脉血栓。
在本实施例中，所述第三治疗单元预防深静脉血栓的方法是：(1)电能药 线负压综合引流伤口使皮下积液和凝血因子渗出，(2)电干扰凝血因子，促其快速分解。(3)电刺激小腿肌肉，促进肌肉收缩静脉血流加快(4)电加快愈合，凝血因子数量减少(5)电止痛，活动无障碍(6)电气压小腿，使回心血量增加。
参考图3，在本实施例中，所述伤口治疗模块包括：第三药线、第三无纺布、第三吸水棉、第三吸管盘、用于与负压吸引装置连接后吸出伤口上液体的第三负压管和两个第三金属导线插口；
所述第三吸水棉设置在所述第三无纺布上的中部位置；所述第三药线设置在所述第三吸水棉上；所述第三吸管盘设置在所述第三吸水棉上的中部并与第三负压管连接；两个所述第三金属导线插口(通过水凝胶)分别设置在第三无纺布上并排列在所述第三吸水棉两侧并分别与所述电气压负压电能刺激综合治疗机连接。
参考图4，在本实施例中，所述辅助治疗模块包括：第四药线、第四无纺布、第四吸水棉、气囊袋和两个第四金属导线插口；
所述第四吸水棉设置在所述第四无纺布上的中部位置；所述第四药线设置在所述第四吸水棉上；两个所述第四金属导线插口(通过水凝胶)分别设置在第四无纺布上并排列在所述第四吸水棉两侧，且分别与所述电气压负压电能刺激综合治疗机连接；所述气囊袋设置在相反于所述第四吸水棉的第四无纺布的另一面上。
在本实施例中，所述第三药线混配用于治疗高凝高危患者的具有活血化淤作用的第三混配药；
所述第三混配药包括：三七、红花、香橼、黄芪、党参、川芎、青皮、桃仁、赤芍、枳壳、香附各10g，丹参、蒲黄、白术、山药、乳香、柴胡、川楝子、太子参、炙甘草各8g和阿斯匹林1g。
在本实施例中，所述第三药线不混配所述第三混配药时，用于非高凝高危患者的治疗。
在本实施例中，所述水凝胶中混配所述金属离子，混配金属离子的水凝胶覆盖到伤口时，吸附并激活带负电荷的生长因子和蛋白酶向伤口聚集，加速伤口愈合。
在本实施例中，所述金属离子为钾离子或钾离子、钠离子、钙离子和镁离子 的混合离子。
在本实施例中，所述钾离子的主要生理功能是维持细胞的新陈代谢，激活蛋白酶的活性；
所述钠离子在体内有助神经、肌肉的正常运作；
所述钙离子为凝血因子，并激活凝血因子参与凝血过程；
所述镁离子用于激活人体多种酶的活性。
在本实施例中，所述第四药线混配所述第三混配药或不混配任何药物。
在本实施例中，所述第一无纺布、第二无纺布、第三无纺布和第四无纺布均可用PU膜代替。
以上对本发明实施例所提供的一种药线引流治疗装置进行了详细介绍。以上实施例的说明只是用于帮助理解本发明的方法及其核心思想；同时，对于本领域的一般技术人员，依据本发明的思想，在具体实施方式及应用范围上均会有改变之处，综上所述，本说明书内容不应理解为对本发明的限制。
如在说明书及权利要求书当中使用了某些词汇来指称特定组件。本领域技术人员应可理解，硬件制造商可能会用不同名词来称呼同一个组件。本说明书及权利要求书并不以名称的差异来作为区分组件的方式，而是以组件在功能上的差异来作为区分的准则。如在通篇说明书及权利要求书当中所提及的“包含”、“包括”为一开放式用语，故应解释成“包含/包括但不限定于”。“大致”是指在可接收的误差范围内，本领域技术人员能够在一定误差范围内解决所述技术问题，基本达到所述技术效果。说明书后续描述为实施本发明的较佳实施方式，然所述描述乃以说明本发明的一般原则为目的，并非用以限定本发明的范围。本发明的保护范围当视所附权利要求书所界定者为准。
还需要说明的是，术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含，从而使得包括一系列要素的商品或者系统不仅包括那些要素，而且还包括没有明确列出的其他要素，或者是还包括为这种商品或者系统所固有的要素。在没有更多限制的情况下，由语句“包括一个……”限定的要素，并不排除在包括所述要素的商品或者系统中还存在另外的相同要素。
应当理解，本文中使用的术语“和/或”仅仅是一种描述关联对象的关联关系，表示可以存在三种关系，例如，A和/或B，可以表示：单独存在A，同时存 在A和B，单独存在B这三种情况。另外，本文中字符“/”，一般表示前后关联对象是一种“或”的关系。
上述说明示出并描述了本发明的若干优选实施例，但如前所述，应当理解本发明并非局限于本文所披露的形式，不应看作是对其他实施例的排除，而可用于各种其他组合、修改和环境，并能够在本文所述申请构想范围内，通过上述教导或相关领域的技术或知识进行改动。而本领域人员所进行的改动和变化不脱离本发明的精神和范围，则都应在本发明所附权利要求书的保护范围内。

Claims (10)

  1. 一种药线引流治疗装置，其特征在于，所述治疗装置包括：
    第一治疗单元，用于术后止痛；
    第二治疗单元，用于促进伤口快速愈合；
    第三治疗单元，用于预防深静脉血栓；
    电气压负压电能刺激综合治疗机，分别与所述第一治疗单元、第二治疗单元和第三治疗单元连接并提供电气压负压电能。
  2. 根据权利要求1所述的一种药线引流治疗装置，其特征在于，所述第一治疗单元包括：第一药线、第一无纺布、第一吸水棉、两个第一吸管盘、用于与负压吸引装置连接后吸出伤口上液体的第一负压管、第一减压管和两个第一金属导线插口；
    所述第一吸水棉设置在所述第一无纺布上的中部位置；所述第一药线设置在所述第一吸水棉上；两个所述第一吸管盘的盘部分别设置在所述第一吸水棉的两端上，一个所述第一吸管盘的管部与第一负压管连接，另一个所述第一吸管盘管部与第一减压管连接；两个所述第一金属导线插口通过水凝胶分别设置在所述第一无纺布上两角并分别与所述电气压负压电能刺激综合治疗机连接。
  3. 根据权利要求2所述的一种药线引流治疗装置，其特征在于，采用第一胶体均匀涂在所述第一吸水棉所在面的所述第一无纺布上，用以将所述第一药线与第一吸水棉覆盖伤口固定。
  4. 根据权利要求2所述的一种药线引流治疗装置，其特征在于，所述第一药线用于非手术创面时不浸润药物，用于伤口浸润麻醉时浸润利多卡因乳膏，用于伤口止痛时浸润第一混配药。
  5. 根据权利要求1所述的一种药线引流治疗装置，其特征在于，所述第二治疗单元包括：第二药线、第二无纺布、第二吸水棉、两个第二吸管盘、用于与负压吸引装置连接后吸出伤口上液体的第二负压管、用于给伤口提供氧的供氧管、用于清洗伤口的冲洗管和两个第二金属导线插口；
    所述第二吸水棉设置在所述第二无纺布上的中部位置；所述第二药线设置在所述第二吸水棉上；两个所述第二吸管盘的盘部分别设置在所述第二吸水棉上同侧的边缘两端，一个所述第二吸管盘管部与第二负压管连接，另一个所述第二吸管盘管部与所述供氧管和冲洗管分别连接；两个所述第二金属导线插口通过水凝 胶分别设置在第二无纺布上并排列在所述第二吸水棉两侧且分别与所述电气压负压电能刺激综合治疗机连接。
  6. 根据权利要求5所述的一种药线引流治疗装置，其特征在于，所述第二药线上粘附第二混配药或金属离子。
  7. 根据权利要求1所述的一种药线引流治疗装置，其特征在于，所述第三治疗单元包括：用于伤口处的伤口治疗模块和两个用于贴在双下肢小腿肌肉上的辅助治疗模块；
    所述伤口治疗模块和辅助治疗模块分别与所述电气压负压电能刺激综合治疗机连接。
  8. 根据权利要求7所述的一种药线引流治疗装置，其特征在于，所述伤口治疗模块包括：第三药线、第三无纺布、第三吸水棉、第三吸管盘、用于与负压吸引装置连接后吸出伤口上液体的第三负压管和两个第三金属导线插口；
    所述第三吸水棉设置在所述第三无纺布上的中部位置；所述第三药线设置在所述第三吸水棉上；所述第三吸管盘设置在所述第三吸水棉上的中部并与第三负压管连接；两个所述第三金属导线插口通过水凝胶分别设置在第三无纺布上并排列在所述第三吸水棉两侧并分别与所述电气压负压电能刺激综合治疗机连接。
  9. 根据权利要求7所述的一种药线引流治疗装置，其特征在于，所述辅助治疗模块包括：第四药线、第四无纺布、第四吸水棉、气囊袋和两个第四金属导线插口；
    所述第四吸水棉设置在所述第四无纺布上的中部位置；所述第四药线设置在所述第四吸水棉上；两个所述第四金属导线插口通过水凝胶分别设置在第四无纺布上并排列在所述第四吸水棉两侧，且分别与所述电气压负压电能刺激综合治疗机连接；所述气囊袋设置在相反于所述第四吸水棉的第四无纺布的另一面上。
  10. 根据权利要求8所述的一种药线引流治疗装置，其特征在于，所述第三药线混配用于治疗高凝高危患者的具有活血化淤作用的第三混配药。
PCT/CN2020/096588 2019-06-26 2020-06-17 一种药线引流治疗装置 WO2020259367A1 (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US17/595,506 US20220265476A1 (en) 2019-06-26 2020-06-17 Medicated thread drainage therapy apparatus

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201910562453 2019-06-26
CN201910562453.6 2019-06-26

Publications (1)

Publication Number Publication Date
WO2020259367A1 true WO2020259367A1 (zh) 2020-12-30

Family

ID=68258482

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2020/096588 WO2020259367A1 (zh) 2019-06-26 2020-06-17 一种药线引流治疗装置

Country Status (3)

Country Link
US (1) US20220265476A1 (zh)
CN (1) CN110368583A (zh)
WO (1) WO2020259367A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110368583A (zh) * 2019-06-26 2019-10-25 龙丹 一种药线引流治疗装置
CN112933310A (zh) * 2021-02-08 2021-06-11 龙丹 一种负压辅助引流治疗装置

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010093753A1 (en) * 2009-02-12 2010-08-19 Perfuzia Medical, Inc. Devices and methods for manipulating circulation in the circulatory system of a patient
CN101991484A (zh) * 2010-11-04 2011-03-30 龙丹 一种创伤疼痛快速康复敷贴仪
CN102836503A (zh) * 2012-09-19 2012-12-26 龙丹 一种新型敷贴综合治疗仪
CN202859914U (zh) * 2012-09-19 2013-04-10 龙丹 一种新型敷贴综合治疗仪
CN204745115U (zh) * 2015-07-21 2015-11-11 龙丹 药线引流治疗及负压辅助愈合治疗仪
CN105497993A (zh) * 2015-07-21 2016-04-20 龙丹 药线引流治疗及负压辅助愈合治疗仪
CN107281640A (zh) * 2017-07-21 2017-10-24 龙丹 一种创伤镇痛快速康复药线引流治疗仪
CN110368583A (zh) * 2019-06-26 2019-10-25 龙丹 一种药线引流治疗装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2244678A4 (en) * 2008-02-10 2013-01-16 Empire Bio Medical Devices Inc DEVICE AND METHOD FOR IMPROVED WOUND TREATMENT
CN105879203A (zh) * 2016-05-12 2016-08-24 河南汇博医疗股份有限公司 一种创面负压综合治疗装置
CN208808808U (zh) * 2017-12-07 2019-05-03 戴全钦 预防深静脉血栓形成的装置
CN212016454U (zh) * 2019-06-26 2020-11-27 龙丹 一种药线引流治疗装置

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010093753A1 (en) * 2009-02-12 2010-08-19 Perfuzia Medical, Inc. Devices and methods for manipulating circulation in the circulatory system of a patient
CN101991484A (zh) * 2010-11-04 2011-03-30 龙丹 一种创伤疼痛快速康复敷贴仪
CN102836503A (zh) * 2012-09-19 2012-12-26 龙丹 一种新型敷贴综合治疗仪
CN202859914U (zh) * 2012-09-19 2013-04-10 龙丹 一种新型敷贴综合治疗仪
CN204745115U (zh) * 2015-07-21 2015-11-11 龙丹 药线引流治疗及负压辅助愈合治疗仪
CN105497993A (zh) * 2015-07-21 2016-04-20 龙丹 药线引流治疗及负压辅助愈合治疗仪
CN106039557A (zh) * 2015-07-21 2016-10-26 龙丹 药线引流治疗仪
CN107281640A (zh) * 2017-07-21 2017-10-24 龙丹 一种创伤镇痛快速康复药线引流治疗仪
CN110368583A (zh) * 2019-06-26 2019-10-25 龙丹 一种药线引流治疗装置

Also Published As

Publication number Publication date
CN110368583A (zh) 2019-10-25
US20220265476A1 (en) 2022-08-25

Similar Documents

Publication Publication Date Title
CN101214286B (zh) 一种有效治疗风湿性疼痛病的中药白酒制剂
CN101703603B (zh) 治疗烧伤的外用软膏及其制备方法
WO2020259367A1 (zh) 一种药线引流治疗装置
CN103041177B (zh) 一种治疗糖尿病足的中药
CN103977113B (zh) 一种治疗糖尿病足的中药
CN105434972A (zh) 一种治疗乳腺增生的中药组合物
CN105535508A (zh) 一种芪竭愈创膏及制备方法
CN102406870B (zh) 一种治疗风湿痹痛的药物
CN103690813B (zh) 一种治疗放射性皮炎的中药外敷剂
CN105998553A (zh) 一种治疗跌打损伤骨折的中药
CN1231243C (zh) 一种治疗风湿疼痛的药物
CN103768290A (zh) 一种治疗滑膜炎的中药组合物及其制备方法
CN1167437C (zh) 一种治疗鸡眼、跖疣的药物
CN105920164A (zh) 术后伤口止痛药贴
CN1242798C (zh) 外敷止咳用中药
CN1233344C (zh) 一种治疗痔疮的外用药
CN105327290A (zh) 一种治疗糖尿病坏疽的外用中药及其制备方法
CN105902847A (zh) 一种治疗前列腺增生的中药组合物
CN105770655A (zh) 一种治疗阴囊湿疹的中药组合物
CN105125822A (zh) 一种治疗下肢骨折术后肿胀的中药组合物
CN101543552B (zh) 一种治疗淋巴结肿大的中药制剂
CN103356747A (zh) 丁桂散脐贴治疗慢性前列腺炎
CN204411492U (zh) 一种治疗腰痛的外用中药袋
CN105497076A (zh) 含水蛭提取物加蜂蜡的透皮吸收药膜的制备
CN1209160C (zh) 治疗中枢神经损伤后瘫痪的中药透皮膜剂及其制备方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20830826

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20830826

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 20830826

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 05.07.2022)

122 Ep: pct application non-entry in european phase

Ref document number: 20830826

Country of ref document: EP

Kind code of ref document: A1